- Home
- OPTT vs ANL Comparison
OPTT vs ANL Comparison
Compare OPTT & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | OPTT | ANL |
|---|---|---|
| Founded | 1984 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 62.0M |
| IPO Year | 2007 | 2023 |
Fundamental Metrics
Financial Performance| Metric | OPTT | ANL |
|---|---|---|
| Price | $0.41 | $1.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 12.6M | 1.3M |
| Earning Date | 12-15-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,748,000.00 | N/A |
| Revenue This Year | $70.98 | N/A |
| Revenue Next Year | $106.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.29 | $0.88 |
| 52 Week High | $1.04 | $2.75 |
Technical Indicators
Market Signals| Indicator | OPTT | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 64.46 |
| Support Level | $0.29 | $1.48 |
| Resistance Level | $0.55 | $1.71 |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 44.18 | 80.95 |
Price Performance
Historical ComparisonAbout OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.